Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?
There exist controversial and discrepant results on the risk of spontaneous abortions and teratogenesis induced by interferon treatment in people with MS.Aim of this study is to evaluate risks of the administration of INFbeta related not only to the foetus, but also to children development up to 12-months developmental milestones.